Evaluation of the prevalence of coronary artery disease in patients with valvular heart disease

Simple item page
dc.contributor.authorEmren Z.Y.
dc.contributor.authorEmren S.V.
dc.contributor.authorKiliçaslan B.
dc.contributor.authorSolmaz H.
dc.contributor.authorSusam I.
dc.contributor.authorSayin A.
dc.contributor.authorAbud B.
dc.contributor.authorAydin M.
dc.contributor.authorBayturan Ö.
dc.date.accessioned2024-07-22T08:15:29Z
dc.date.available2024-07-22T08:15:29Z
dc.date.issued2014
dc.description.abstractObjectives: The aim of the present study was to retrospectively evaluate the prevalence of concurrent coronary artery disease in patients who underwent surgery due to severe valvular heart disease. The study also investigated the association of coronary artery disease with the type of valvular heart disease.Materials and methods: A total of 241 patients (123 females [51%]), who had underwent single valvular heart surgery, were included in the study. The patients who underwent valve replacement surgery were divided into four groups: patients with severe mitral stenosis (MS), patients with severe mitral regurgitation (MR), patients with severe aortic regurgitation (AR), and patients with severe aortic stenosis (AS). Age, DM, HT, history of smoking, and LDL values were recorded as the risk factors for CAD.Results: Coronary artery disease was detected in 26.4% of patients with mitral stenosis and 57.7% of patients with aortic stenosis. Of the patients with mitral insufficiency, 41.9% had CAD, and 44.4% of the patients with aortic insufficiency had CAD.Conclusion: The comparison of MS and AS groups revealed significantly higher prevalence of CAD in the AS group. There was no statistically significant difference between the MR and AR groups in terms of the prevalence of CAD. The comparison of MS and MR groups revealed significantly higher prevalence of CAD in the MR group. Furthermore, the comparison of these groups in terms of the extensiveness of the coronary artery disease revealed significantly higher Gensini score in the MR group. © 2014 Emren et al.; licensee BioMed Central Ltd.
dc.identifier.DOI-ID10.1186/s13019-014-0153-1
dc.identifier.issn17498090
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/16737
dc.language.isoEnglish
dc.publisherBioMed Central Ltd.
dc.rightsAll Open Access; Gold Open Access; Green Open Access
dc.subjectAdult
dc.subjectAged
dc.subjectAortic Valve Insufficiency
dc.subjectAortic Valve Stenosis
dc.subjectCoronary Artery Disease
dc.subjectFemale
dc.subjectHeart Valve Diseases
dc.subjectHeart Valve Prosthesis Implantation
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectMitral Valve Insufficiency
dc.subjectMitral Valve Stenosis
dc.subjectPrevalence
dc.subjectRetrospective Studies
dc.subjectRisk Factors
dc.subjectTurkey
dc.subjectadult
dc.subjectaged
dc.subjectAortic Valve Insufficiency
dc.subjectAortic Valve Stenosis
dc.subjectclinical trial
dc.subjectcomplication
dc.subjectcoronary artery disease
dc.subjectfemale
dc.subjectHeart Valve Diseases
dc.subjectheart valve replacement
dc.subjecthuman
dc.subjectmale
dc.subjectmiddle aged
dc.subjectMitral Valve Insufficiency
dc.subjectmitral valve stenosis
dc.subjectmulticenter study
dc.subjectprevalence
dc.subjectretrospective study
dc.subjectrisk factor
dc.subjectTurkey
dc.titleEvaluation of the prevalence of coronary artery disease in patients with valvular heart disease
dc.typeArticle

Files

Collections

Scopus Koleksiyonu